Compare Machhar Industri with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.87%
- Poor long term growth as Net Sales has grown by an annual rate of 1.21% and Operating profit at 15.76% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.57
Falling Participation by Institutional Investors
Stock DNA
Specialty Chemicals
INR 29 Cr (Micro Cap)
38.00
31
0.00%
-0.29
5.99%
2.86
Total Returns (Price + Dividend) 
Machhar Industri for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Machhar Industries Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Machhar Industries Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Hold to Sell as of 3 September 2026. This revision reflects a complex interplay of deteriorating technical indicators, subdued financial trends, and weak long-term fundamentals despite recent positive quarterly results and market-beating stock returns.
Read full news article
MarketsMOJO Upgrades Machhar Industries Ltd to Hold on Improved Technicals and Financial Trends
Machhar Industries Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 2 September 2026, is underpinned by enhanced technical trends, positive quarterly financial performance, and market-beating returns over the past year, despite lingering concerns over long-term fundamentals and institutional participation.
Read full news article
Machhar Industries Ltd Upgraded to Sell on Technical Improvements and Mixed Financials
Machhar Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 11 August 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak long-term fundamentals and subdued financial trends.
Read full news article Announcements 
Closure of Trading Window
27-Aug-2026 | Source : BSEIntimation of Book closure for the purpose of 18th Annual General Meeting (AGM) to be held on 22nd September 2026
Reg. 34 (1) Annual Report.
25-Aug-2026 | Source : BSEPursuant to Regulation 34(1) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit the Annual Report of the Company for the Financial Year 2025-26 along with the Notice convening the 18th Annual General Meeting of the Members of the Company scheduled to be held on Tuesday 22nd September 2026.
Intimation Of Notice Of 18Th Annual General Meeting (AGM) Of Company.
25-Aug-2026 | Source : BSE Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.04%)
Held by 0 FIIs
Arvind Krishnagopal Machhar (15.63%)
Reliance Capital Trustee Co Ltd (3.37%)
35.17%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 37.25% vs 8.85% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 81.25% vs -44.83% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -14.92% vs 4.92% in Sep 2024
Growth in half year ended Sep 2025 is -6.67% vs 7.14% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -4.54% vs -0.77% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 514.29% vs -58.82% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -0.77% vs -7.38% in Mar 2025
YoY Growth in year ended Mar 2026 is 286.67% vs -74.14% in Mar 2025






